Arsenal Capital Partners

The firm operates as a traditional sector‑focused private equity general partner. It establishes closed‑end funds (core buyout and growth vehicles), raises commitments from institutional limited partners, and deploys this capital into control or significant minority stakes in middle‑market specialty industrial and healthcare companies. It builds platforms through add‑on acquisitions and operational improvement, then realises investments through sales to strategic buyers or other financial sponsors. Value is created via financial structuring, consolidation in fragmented niches, and operational initiatives across portfolio platforms (for example in specialty chemicals, temperature‑assured packaging, automation, and life‑sciences tools). Fund performance drives the firm’s long‑term economics and ability to raise successor vehicles.

Arsenal Capital Partners is a United States–based private equity investment firm focused on middle‑market specialty industrial and healthcare businesses. It raises closed‑end buyout and growth funds from institutional investors, uses this capital to acquire and build platform companies, and exits via trade sales or secondary transactions.

The firm creates value through sector‑specialist investing and active company building, including buy‑and‑build strategies in areas such as specialty chemicals, packaging, automation, and life sciences tools. Its direct customers are institutional limited partners that commit capital to its funds; indirectly it also engages with portfolio companies that pay monitoring and transaction fees.